返回
CARsgen Therapeutics Holdings Limited（02171.HK）价格
02171.HK 股价走势图
CARSGEN-B (02171.HK)
CARsgen Therapeutics Holdings Limited
HK$16.19
-1.22%
$-0.19
休市： Jan 16, 16:00:00 HKT
关键数据
前收盘价
$16.39
开盘价
$16.39
当日区间
$15.87 - $16.6
52周范围
$8.5 - $25.6
交易量
1.3M
平均成交量
1.7M
每股收益（TTM）
-1.06
股息收益率
--
市值
$8.8B
什么是 CARSGEN-B？
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 371 full-time employees. The company went IPO on 2021-06-18. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The firm conducts its business in the domestic and overseas markets.